Sakiko Tsugawa

Shinjuku, 1608582, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

Association between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Trial.

Association between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Trial.

Journal: Pharmacopsychiatry
Published: July 07, 2026

Neurometabolites and Antipsychotic Response in Psychosis: A Mega-Analysis.

Neurometabolites and Antipsychotic Response in Psychosis: A Mega-Analysis.

Journal: JAMA psychiatry
Published: June 24, 2026

Glutathione-Related Metabolite Levels and Enzyme Activities in Depression: A Systematic Review and Meta-Analysis.

Glutathione-Related Metabolite Levels and Enzyme Activities in Depression: A Systematic Review and Meta-Analysis.

Journal: Neuropsychopharmacology reports
Published: December 11, 2025

Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophrenia.

Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophrenia.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: July 07, 2025

Machine Learning-Based Discrimination of Treatment-Resistant Schizophrenia Using Structural Brain Imaging: A Multi-Site Proof-of-Concept Study.

Machine Learning-Based Discrimination of Treatment-Resistant Schizophrenia Using Structural Brain Imaging: A Multi-Site Proof-of-Concept Study.

Journal: Biological psychiatry
Published: June 25, 2025

Repetitive Transcranial Magnetic Stimulation as Maintenance Treatment of Depression: The MAINT-R Randomized Clinical Trial.

Repetitive Transcranial Magnetic Stimulation as Maintenance Treatment of Depression: The MAINT-R Randomized Clinical Trial.

Journal: JAMA network open
Published: June 16, 2025

Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distribution.

Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distribution.

Journal: Frontiers in neural circuits
Published: May 07, 2025

The dynamics of AMPA receptors underlies the efficacy of ketamine in treatment resistant patients with depression.

The dynamics of AMPA receptors underlies the efficacy of ketamine in treatment resistant patients with depression.

Journal: Molecular psychiatry
Published: April 14, 2025

Systemic increase of AMPA receptors associated with cognitive impairment of long COVID.

Systemic increase of AMPA receptors associated with cognitive impairment of long COVID.

Journal: Brain communications
Published: March 03, 2025

Abnormal neuritic microstructures in the anterior limb of internal capsules in treatment-resistant depression - A cross-sectional NODDI study.

Abnormal neuritic microstructures in the anterior limb of internal capsules in treatment-resistant depression - A cross-sectional NODDI study.

Journal: Journal of psychiatric research
Published: December 31, 2024

Evaluation of GABAergic and Glutamatergic Levels in the Dorsal Anterior Cingulate Cortex of Patients With Bipolar Disorder: A Cross-Sectional 1H-MRS Study.

Evaluation of GABAergic and Glutamatergic Levels in the Dorsal Anterior Cingulate Cortex of Patients With Bipolar Disorder: A Cross-Sectional 1H-MRS Study.

Journal: Neuropsychopharmacology reports
Published: December 03, 2024

Corrigendum: α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor density underlies intraregional and interregional functional centrality.

Corrigendum: α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor density underlies intraregional and interregional functional centrality.

Journal: Frontiers in neural circuits
Published: November 22, 2024
Showing 1-12 of 53

Last Updated: 09/26/2026